TechFlow news, January 24 — According to PR Newswire, medical technology company Semler Scientific (Nasdaq: SMLR) announced plans to offer $75 million in aggregate principal amount of convertible senior notes due 2030 to qualified institutional buyers, with an additional $15 million potentially available through a greenshoe option.
The company stated that proceeds from the offering will be partially used to pay the cost of capped call transactions, with the remainder allocated for general corporate purposes, including the purchase of bitcoin. Semler Scientific focuses on developing diagnostic devices for cardiovascular diseases, and its flagship product, QuantaFlo, has received FDA clearance. The company has adopted bitcoin as its primary reserve asset.
